Medical Care

Global Regulatory T Cell Tregs Therapies Market Research Report 2025

The global market for Regulatory T Cell Tregs Therapies was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Regulatory T Cell Tregs Therapies is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Regulatory T Cell Tregs Therapies is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Regulatory T Cell Tregs Therapies in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Regulatory T Cell Tregs Therapies include Abata Therapeutics, Cellenkos Inc, Coya Therapeutics, Roche, Caladrius Biosciences, Sonoma Biotherapeutics, Nektar Therapeutics, Eli Lilly And Company, Regimmune, Miltenyi Biotec, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Regulatory T Cell Tregs Therapies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Regulatory T Cell Tregs Therapies.
The Regulatory T Cell Tregs Therapies market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Regulatory T Cell Tregs Therapies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Regulatory T Cell Tregs Therapies companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abata Therapeutics
Cellenkos Inc
Coya Therapeutics
Roche
Caladrius Biosciences
Sonoma Biotherapeutics
Nektar Therapeutics
Eli Lilly And Company
Regimmune
Miltenyi Biotec
Teraimmune
Tract Therapeutics
Vt Bio
Amgen
Sangamo Therapeutics (Txcell)
Pfizer Inc
Poltreg Sa
Parvus Therapeutics
Celgene
Segment by Type
Tregs
Interleukin 2
Monoclonal Antibodies
Others
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Regulatory T Cell Tregs Therapies company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Regulatory T Cell Tregs Therapies Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Tregs
1.2.3 Interleukin 2
1.2.4 Monoclonal Antibodies
1.2.5 Others
1.3 Market by Application
1.3.1 Global Regulatory T Cell Tregs Therapies Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Regulatory T Cell Tregs Therapies Market Perspective (2020-2031)
2.2 Global Regulatory T Cell Tregs Therapies Growth Trends by Region
2.2.1 Global Regulatory T Cell Tregs Therapies Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Regulatory T Cell Tregs Therapies Historic Market Size by Region (2020-2025)
2.2.3 Regulatory T Cell Tregs Therapies Forecasted Market Size by Region (2026-2031)
2.3 Regulatory T Cell Tregs Therapies Market Dynamics
2.3.1 Regulatory T Cell Tregs Therapies Industry Trends
2.3.2 Regulatory T Cell Tregs Therapies Market Drivers
2.3.3 Regulatory T Cell Tregs Therapies Market Challenges
2.3.4 Regulatory T Cell Tregs Therapies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Regulatory T Cell Tregs Therapies Players by Revenue
3.1.1 Global Top Regulatory T Cell Tregs Therapies Players by Revenue (2020-2025)
3.1.2 Global Regulatory T Cell Tregs Therapies Revenue Market Share by Players (2020-2025)
3.2 Global Regulatory T Cell Tregs Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Regulatory T Cell Tregs Therapies Revenue
3.4 Global Regulatory T Cell Tregs Therapies Market Concentration Ratio
3.4.1 Global Regulatory T Cell Tregs Therapies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Regulatory T Cell Tregs Therapies Revenue in 2024
3.5 Global Key Players of Regulatory T Cell Tregs Therapies Head office and Area Served
3.6 Global Key Players of Regulatory T Cell Tregs Therapies, Product and Application
3.7 Global Key Players of Regulatory T Cell Tregs Therapies, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Regulatory T Cell Tregs Therapies Breakdown Data by Type
4.1 Global Regulatory T Cell Tregs Therapies Historic Market Size by Type (2020-2025)
4.2 Global Regulatory T Cell Tregs Therapies Forecasted Market Size by Type (2026-2031)
5 Regulatory T Cell Tregs Therapies Breakdown Data by Application
5.1 Global Regulatory T Cell Tregs Therapies Historic Market Size by Application (2020-2025)
5.2 Global Regulatory T Cell Tregs Therapies Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Regulatory T Cell Tregs Therapies Market Size (2020-2031)
6.2 North America Regulatory T Cell Tregs Therapies Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Regulatory T Cell Tregs Therapies Market Size by Country (2020-2025)
6.4 North America Regulatory T Cell Tregs Therapies Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Regulatory T Cell Tregs Therapies Market Size (2020-2031)
7.2 Europe Regulatory T Cell Tregs Therapies Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Regulatory T Cell Tregs Therapies Market Size by Country (2020-2025)
7.4 Europe Regulatory T Cell Tregs Therapies Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Regulatory T Cell Tregs Therapies Market Size (2020-2031)
8.2 Asia-Pacific Regulatory T Cell Tregs Therapies Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Regulatory T Cell Tregs Therapies Market Size by Region (2020-2025)
8.4 Asia-Pacific Regulatory T Cell Tregs Therapies Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Regulatory T Cell Tregs Therapies Market Size (2020-2031)
9.2 Latin America Regulatory T Cell Tregs Therapies Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Regulatory T Cell Tregs Therapies Market Size by Country (2020-2025)
9.4 Latin America Regulatory T Cell Tregs Therapies Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Regulatory T Cell Tregs Therapies Market Size (2020-2031)
10.2 Middle East & Africa Regulatory T Cell Tregs Therapies Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Regulatory T Cell Tregs Therapies Market Size by Country (2020-2025)
10.4 Middle East & Africa Regulatory T Cell Tregs Therapies Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abata Therapeutics
11.1.1 Abata Therapeutics Company Details
11.1.2 Abata Therapeutics Business Overview
11.1.3 Abata Therapeutics Regulatory T Cell Tregs Therapies Introduction
11.1.4 Abata Therapeutics Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025)
11.1.5 Abata Therapeutics Recent Development
11.2 Cellenkos Inc
11.2.1 Cellenkos Inc Company Details
11.2.2 Cellenkos Inc Business Overview
11.2.3 Cellenkos Inc Regulatory T Cell Tregs Therapies Introduction
11.2.4 Cellenkos Inc Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025)
11.2.5 Cellenkos Inc Recent Development
11.3 Coya Therapeutics
11.3.1 Coya Therapeutics Company Details
11.3.2 Coya Therapeutics Business Overview
11.3.3 Coya Therapeutics Regulatory T Cell Tregs Therapies Introduction
11.3.4 Coya Therapeutics Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025)
11.3.5 Coya Therapeutics Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Regulatory T Cell Tregs Therapies Introduction
11.4.4 Roche Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025)
11.4.5 Roche Recent Development
11.5 Caladrius Biosciences
11.5.1 Caladrius Biosciences Company Details
11.5.2 Caladrius Biosciences Business Overview
11.5.3 Caladrius Biosciences Regulatory T Cell Tregs Therapies Introduction
11.5.4 Caladrius Biosciences Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025)
11.5.5 Caladrius Biosciences Recent Development
11.6 Sonoma Biotherapeutics
11.6.1 Sonoma Biotherapeutics Company Details
11.6.2 Sonoma Biotherapeutics Business Overview
11.6.3 Sonoma Biotherapeutics Regulatory T Cell Tregs Therapies Introduction
11.6.4 Sonoma Biotherapeutics Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025)
11.6.5 Sonoma Biotherapeutics Recent Development
11.7 Nektar Therapeutics
11.7.1 Nektar Therapeutics Company Details
11.7.2 Nektar Therapeutics Business Overview
11.7.3 Nektar Therapeutics Regulatory T Cell Tregs Therapies Introduction
11.7.4 Nektar Therapeutics Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025)
11.7.5 Nektar Therapeutics Recent Development
11.8 Eli Lilly And Company
11.8.1 Eli Lilly And Company Company Details
11.8.2 Eli Lilly And Company Business Overview
11.8.3 Eli Lilly And Company Regulatory T Cell Tregs Therapies Introduction
11.8.4 Eli Lilly And Company Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025)
11.8.5 Eli Lilly And Company Recent Development
11.9 Regimmune
11.9.1 Regimmune Company Details
11.9.2 Regimmune Business Overview
11.9.3 Regimmune Regulatory T Cell Tregs Therapies Introduction
11.9.4 Regimmune Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025)
11.9.5 Regimmune Recent Development
11.10 Miltenyi Biotec
11.10.1 Miltenyi Biotec Company Details
11.10.2 Miltenyi Biotec Business Overview
11.10.3 Miltenyi Biotec Regulatory T Cell Tregs Therapies Introduction
11.10.4 Miltenyi Biotec Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025)
11.10.5 Miltenyi Biotec Recent Development
11.11 Teraimmune
11.11.1 Teraimmune Company Details
11.11.2 Teraimmune Business Overview
11.11.3 Teraimmune Regulatory T Cell Tregs Therapies Introduction
11.11.4 Teraimmune Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025)
11.11.5 Teraimmune Recent Development
11.12 Tract Therapeutics
11.12.1 Tract Therapeutics Company Details
11.12.2 Tract Therapeutics Business Overview
11.12.3 Tract Therapeutics Regulatory T Cell Tregs Therapies Introduction
11.12.4 Tract Therapeutics Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025)
11.12.5 Tract Therapeutics Recent Development
11.13 Vt Bio
11.13.1 Vt Bio Company Details
11.13.2 Vt Bio Business Overview
11.13.3 Vt Bio Regulatory T Cell Tregs Therapies Introduction
11.13.4 Vt Bio Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025)
11.13.5 Vt Bio Recent Development
11.14 Amgen
11.14.1 Amgen Company Details
11.14.2 Amgen Business Overview
11.14.3 Amgen Regulatory T Cell Tregs Therapies Introduction
11.14.4 Amgen Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025)
11.14.5 Amgen Recent Development
11.15 Sangamo Therapeutics (Txcell)
11.15.1 Sangamo Therapeutics (Txcell) Company Details
11.15.2 Sangamo Therapeutics (Txcell) Business Overview
11.15.3 Sangamo Therapeutics (Txcell) Regulatory T Cell Tregs Therapies Introduction
11.15.4 Sangamo Therapeutics (Txcell) Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025)
11.15.5 Sangamo Therapeutics (Txcell) Recent Development
11.16 Pfizer Inc
11.16.1 Pfizer Inc Company Details
11.16.2 Pfizer Inc Business Overview
11.16.3 Pfizer Inc Regulatory T Cell Tregs Therapies Introduction
11.16.4 Pfizer Inc Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025)
11.16.5 Pfizer Inc Recent Development
11.17 Poltreg Sa
11.17.1 Poltreg Sa Company Details
11.17.2 Poltreg Sa Business Overview
11.17.3 Poltreg Sa Regulatory T Cell Tregs Therapies Introduction
11.17.4 Poltreg Sa Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025)
11.17.5 Poltreg Sa Recent Development
11.18 Parvus Therapeutics
11.18.1 Parvus Therapeutics Company Details
11.18.2 Parvus Therapeutics Business Overview
11.18.3 Parvus Therapeutics Regulatory T Cell Tregs Therapies Introduction
11.18.4 Parvus Therapeutics Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025)
11.18.5 Parvus Therapeutics Recent Development
11.19 Celgene
11.19.1 Celgene Company Details
11.19.2 Celgene Business Overview
11.19.3 Celgene Regulatory T Cell Tregs Therapies Introduction
11.19.4 Celgene Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025)
11.19.5 Celgene Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Regulatory T Cell Tregs Therapies Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Tregs
Table 3. Key Players of Interleukin 2
Table 4. Key Players of Monoclonal Antibodies
Table 5. Key Players of Others
Table 6. Global Regulatory T Cell Tregs Therapies Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Regulatory T Cell Tregs Therapies Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Regulatory T Cell Tregs Therapies Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Regulatory T Cell Tregs Therapies Market Share by Region (2020-2025)
Table 10. Global Regulatory T Cell Tregs Therapies Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Regulatory T Cell Tregs Therapies Market Share by Region (2026-2031)
Table 12. Regulatory T Cell Tregs Therapies Market Trends
Table 13. Regulatory T Cell Tregs Therapies Market Drivers
Table 14. Regulatory T Cell Tregs Therapies Market Challenges
Table 15. Regulatory T Cell Tregs Therapies Market Restraints
Table 16. Global Regulatory T Cell Tregs Therapies Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Regulatory T Cell Tregs Therapies Market Share by Players (2020-2025)
Table 18. Global Top Regulatory T Cell Tregs Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Regulatory T Cell Tregs Therapies as of 2024)
Table 19. Ranking of Global Top Regulatory T Cell Tregs Therapies Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Regulatory T Cell Tregs Therapies Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Regulatory T Cell Tregs Therapies, Headquarters and Area Served
Table 22. Global Key Players of Regulatory T Cell Tregs Therapies, Product and Application
Table 23. Global Key Players of Regulatory T Cell Tregs Therapies, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Regulatory T Cell Tregs Therapies Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Regulatory T Cell Tregs Therapies Revenue Market Share by Type (2020-2025)
Table 27. Global Regulatory T Cell Tregs Therapies Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Regulatory T Cell Tregs Therapies Revenue Market Share by Type (2026-2031)
Table 29. Global Regulatory T Cell Tregs Therapies Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Regulatory T Cell Tregs Therapies Revenue Market Share by Application (2020-2025)
Table 31. Global Regulatory T Cell Tregs Therapies Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Regulatory T Cell Tregs Therapies Revenue Market Share by Application (2026-2031)
Table 33. North America Regulatory T Cell Tregs Therapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Regulatory T Cell Tregs Therapies Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Regulatory T Cell Tregs Therapies Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Regulatory T Cell Tregs Therapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Regulatory T Cell Tregs Therapies Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Regulatory T Cell Tregs Therapies Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Regulatory T Cell Tregs Therapies Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Regulatory T Cell Tregs Therapies Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Regulatory T Cell Tregs Therapies Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Regulatory T Cell Tregs Therapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Regulatory T Cell Tregs Therapies Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Regulatory T Cell Tregs Therapies Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Regulatory T Cell Tregs Therapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Regulatory T Cell Tregs Therapies Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Regulatory T Cell Tregs Therapies Market Size by Country (2026-2031) & (US$ Million)
Table 48. Abata Therapeutics Company Details
Table 49. Abata Therapeutics Business Overview
Table 50. Abata Therapeutics Regulatory T Cell Tregs Therapies Product
Table 51. Abata Therapeutics Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025) & (US$ Million)
Table 52. Abata Therapeutics Recent Development
Table 53. Cellenkos Inc Company Details
Table 54. Cellenkos Inc Business Overview
Table 55. Cellenkos Inc Regulatory T Cell Tregs Therapies Product
Table 56. Cellenkos Inc Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025) & (US$ Million)
Table 57. Cellenkos Inc Recent Development
Table 58. Coya Therapeutics Company Details
Table 59. Coya Therapeutics Business Overview
Table 60. Coya Therapeutics Regulatory T Cell Tregs Therapies Product
Table 61. Coya Therapeutics Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025) & (US$ Million)
Table 62. Coya Therapeutics Recent Development
Table 63. Roche Company Details
Table 64. Roche Business Overview
Table 65. Roche Regulatory T Cell Tregs Therapies Product
Table 66. Roche Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025) & (US$ Million)
Table 67. Roche Recent Development
Table 68. Caladrius Biosciences Company Details
Table 69. Caladrius Biosciences Business Overview
Table 70. Caladrius Biosciences Regulatory T Cell Tregs Therapies Product
Table 71. Caladrius Biosciences Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025) & (US$ Million)
Table 72. Caladrius Biosciences Recent Development
Table 73. Sonoma Biotherapeutics Company Details
Table 74. Sonoma Biotherapeutics Business Overview
Table 75. Sonoma Biotherapeutics Regulatory T Cell Tregs Therapies Product
Table 76. Sonoma Biotherapeutics Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025) & (US$ Million)
Table 77. Sonoma Biotherapeutics Recent Development
Table 78. Nektar Therapeutics Company Details
Table 79. Nektar Therapeutics Business Overview
Table 80. Nektar Therapeutics Regulatory T Cell Tregs Therapies Product
Table 81. Nektar Therapeutics Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025) & (US$ Million)
Table 82. Nektar Therapeutics Recent Development
Table 83. Eli Lilly And Company Company Details
Table 84. Eli Lilly And Company Business Overview
Table 85. Eli Lilly And Company Regulatory T Cell Tregs Therapies Product
Table 86. Eli Lilly And Company Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025) & (US$ Million)
Table 87. Eli Lilly And Company Recent Development
Table 88. Regimmune Company Details
Table 89. Regimmune Business Overview
Table 90. Regimmune Regulatory T Cell Tregs Therapies Product
Table 91. Regimmune Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025) & (US$ Million)
Table 92. Regimmune Recent Development
Table 93. Miltenyi Biotec Company Details
Table 94. Miltenyi Biotec Business Overview
Table 95. Miltenyi Biotec Regulatory T Cell Tregs Therapies Product
Table 96. Miltenyi Biotec Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025) & (US$ Million)
Table 97. Miltenyi Biotec Recent Development
Table 98. Teraimmune Company Details
Table 99. Teraimmune Business Overview
Table 100. Teraimmune Regulatory T Cell Tregs Therapies Product
Table 101. Teraimmune Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025) & (US$ Million)
Table 102. Teraimmune Recent Development
Table 103. Tract Therapeutics Company Details
Table 104. Tract Therapeutics Business Overview
Table 105. Tract Therapeutics Regulatory T Cell Tregs Therapies Product
Table 106. Tract Therapeutics Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025) & (US$ Million)
Table 107. Tract Therapeutics Recent Development
Table 108. Vt Bio Company Details
Table 109. Vt Bio Business Overview
Table 110. Vt Bio Regulatory T Cell Tregs Therapies Product
Table 111. Vt Bio Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025) & (US$ Million)
Table 112. Vt Bio Recent Development
Table 113. Amgen Company Details
Table 114. Amgen Business Overview
Table 115. Amgen Regulatory T Cell Tregs Therapies Product
Table 116. Amgen Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025) & (US$ Million)
Table 117. Amgen Recent Development
Table 118. Sangamo Therapeutics (Txcell) Company Details
Table 119. Sangamo Therapeutics (Txcell) Business Overview
Table 120. Sangamo Therapeutics (Txcell) Regulatory T Cell Tregs Therapies Product
Table 121. Sangamo Therapeutics (Txcell) Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025) & (US$ Million)
Table 122. Sangamo Therapeutics (Txcell) Recent Development
Table 123. Pfizer Inc Company Details
Table 124. Pfizer Inc Business Overview
Table 125. Pfizer Inc Regulatory T Cell Tregs Therapies Product
Table 126. Pfizer Inc Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025) & (US$ Million)
Table 127. Pfizer Inc Recent Development
Table 128. Poltreg Sa Company Details
Table 129. Poltreg Sa Business Overview
Table 130. Poltreg Sa Regulatory T Cell Tregs Therapies Product
Table 131. Poltreg Sa Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025) & (US$ Million)
Table 132. Poltreg Sa Recent Development
Table 133. Parvus Therapeutics Company Details
Table 134. Parvus Therapeutics Business Overview
Table 135. Parvus Therapeutics Regulatory T Cell Tregs Therapies Product
Table 136. Parvus Therapeutics Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025) & (US$ Million)
Table 137. Parvus Therapeutics Recent Development
Table 138. Celgene Company Details
Table 139. Celgene Business Overview
Table 140. Celgene Regulatory T Cell Tregs Therapies Product
Table 141. Celgene Revenue in Regulatory T Cell Tregs Therapies Business (2020-2025) & (US$ Million)
Table 142. Celgene Recent Development
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report


List of Figures
Figure 1. Regulatory T Cell Tregs Therapies Picture
Figure 2. Global Regulatory T Cell Tregs Therapies Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Regulatory T Cell Tregs Therapies Market Share by Type: 2024 VS 2031
Figure 4. Tregs Features
Figure 5. Interleukin 2 Features
Figure 6. Monoclonal Antibodies Features
Figure 7. Others Features
Figure 8. Global Regulatory T Cell Tregs Therapies Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Regulatory T Cell Tregs Therapies Market Share by Application: 2024 VS 2031
Figure 10. Hospital Case Studies
Figure 11. Clinic Case Studies
Figure 12. Others Case Studies
Figure 13. Regulatory T Cell Tregs Therapies Report Years Considered
Figure 14. Global Regulatory T Cell Tregs Therapies Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Regulatory T Cell Tregs Therapies Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Regulatory T Cell Tregs Therapies Market Share by Region: 2024 VS 2031
Figure 17. Global Regulatory T Cell Tregs Therapies Market Share by Players in 2024
Figure 18. Global Top Regulatory T Cell Tregs Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Regulatory T Cell Tregs Therapies as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Regulatory T Cell Tregs Therapies Revenue in 2024
Figure 20. North America Regulatory T Cell Tregs Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Regulatory T Cell Tregs Therapies Market Share by Country (2020-2031)
Figure 22. United States Regulatory T Cell Tregs Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Regulatory T Cell Tregs Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Regulatory T Cell Tregs Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Regulatory T Cell Tregs Therapies Market Share by Country (2020-2031)
Figure 26. Germany Regulatory T Cell Tregs Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Regulatory T Cell Tregs Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Regulatory T Cell Tregs Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Regulatory T Cell Tregs Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Regulatory T Cell Tregs Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Regulatory T Cell Tregs Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Regulatory T Cell Tregs Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Regulatory T Cell Tregs Therapies Market Share by Region (2020-2031)
Figure 34. China Regulatory T Cell Tregs Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Regulatory T Cell Tregs Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Regulatory T Cell Tregs Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Regulatory T Cell Tregs Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Regulatory T Cell Tregs Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Regulatory T Cell Tregs Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Regulatory T Cell Tregs Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Regulatory T Cell Tregs Therapies Market Share by Country (2020-2031)
Figure 42. Mexico Regulatory T Cell Tregs Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Regulatory T Cell Tregs Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Regulatory T Cell Tregs Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Regulatory T Cell Tregs Therapies Market Share by Country (2020-2031)
Figure 46. Turkey Regulatory T Cell Tregs Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Regulatory T Cell Tregs Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Regulatory T Cell Tregs Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Abata Therapeutics Revenue Growth Rate in Regulatory T Cell Tregs Therapies Business (2020-2025)
Figure 50. Cellenkos Inc Revenue Growth Rate in Regulatory T Cell Tregs Therapies Business (2020-2025)
Figure 51. Coya Therapeutics Revenue Growth Rate in Regulatory T Cell Tregs Therapies Business (2020-2025)
Figure 52. Roche Revenue Growth Rate in Regulatory T Cell Tregs Therapies Business (2020-2025)
Figure 53. Caladrius Biosciences Revenue Growth Rate in Regulatory T Cell Tregs Therapies Business (2020-2025)
Figure 54. Sonoma Biotherapeutics Revenue Growth Rate in Regulatory T Cell Tregs Therapies Business (2020-2025)
Figure 55. Nektar Therapeutics Revenue Growth Rate in Regulatory T Cell Tregs Therapies Business (2020-2025)
Figure 56. Eli Lilly And Company Revenue Growth Rate in Regulatory T Cell Tregs Therapies Business (2020-2025)
Figure 57. Regimmune Revenue Growth Rate in Regulatory T Cell Tregs Therapies Business (2020-2025)
Figure 58. Miltenyi Biotec Revenue Growth Rate in Regulatory T Cell Tregs Therapies Business (2020-2025)
Figure 59. Teraimmune Revenue Growth Rate in Regulatory T Cell Tregs Therapies Business (2020-2025)
Figure 60. Tract Therapeutics Revenue Growth Rate in Regulatory T Cell Tregs Therapies Business (2020-2025)
Figure 61. Vt Bio Revenue Growth Rate in Regulatory T Cell Tregs Therapies Business (2020-2025)
Figure 62. Amgen Revenue Growth Rate in Regulatory T Cell Tregs Therapies Business (2020-2025)
Figure 63. Sangamo Therapeutics (Txcell) Revenue Growth Rate in Regulatory T Cell Tregs Therapies Business (2020-2025)
Figure 64. Pfizer Inc Revenue Growth Rate in Regulatory T Cell Tregs Therapies Business (2020-2025)
Figure 65. Poltreg Sa Revenue Growth Rate in Regulatory T Cell Tregs Therapies Business (2020-2025)
Figure 66. Parvus Therapeutics Revenue Growth Rate in Regulatory T Cell Tregs Therapies Business (2020-2025)
Figure 67. Celgene Revenue Growth Rate in Regulatory T Cell Tregs Therapies Business (2020-2025)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies